Responding to a growing demand from the dietary supplements industry Chr. Hansen's new offering paves the way for powerful supplements containing documented probiotics and fibers.
In a move to support dietary supplements producers who wish to help people tackle constipation, the Danish bioscience company launches a concept combining efficacious probiotics and beneficial fibers. "We are experiencing an increased demand in this product area," says Charlotte Beyerholm, Marketing Manager, Human Health & Nutrition. "Constipation is a widespread health concern globally. 12 percent of people worldwide suffer from self-defined constipation according to a 2006 global omnibus study involving 13,900 individuals."
"We have documented effect on constipation with some of our premium probiotic strains, e.g. BB-12®", says Beyerholm. "Together with carefully select fibers, we have an excellent combination to tackle constipation", she continues. The ingredients combination represents an attractive "2 in 1" or "double action" product.
The supplement format is a 6 g stick with powder to be sifted over breakfast cereals or poured into a glass of water daily or twice a day.
Chr. Hansen at SupplySide West 2011
Chr. Hansen’s probiotic experts will be in place at the SupplySide West 2011 trade show (booth #20042) and be ready to discuss the business opportunities of its visitors and share their knowledge about the probiotic market and consumer preferences.
“During the last couple of years Chr. Hansen has experienced an increased demand from the US market of our documented probiotic strains”, says Sales Manager Brian Peeters. “We see the focus being directed towards our science-based probiotic products in the US. This is completely in line with Chr. Hansen’s promise to deliver a product which is clinically documented and safe, and which meets the label claim throughout the whole shelf life of the product.”
For more information about Chr. Hansen’s probiotics: probiotics/humanhealth
Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. The products include cultures, enzymes, probiotics and natural colors, and all solutions are based on strong research and development competencies coupled with significant technology investments. Revenue in the 2013/14 financial year was EUR 756 million. The company holds a leading market position in all its divisions: Cultures & Enzymes, Health & Nutrition and Natural Colors. It has more than 2,500 dedicated employees in over 30 countries and main production facilities in Denmark, France, USA and Germany. Chr. Hansen was founded in 1874 and is listed on NASDAQ OMX Copenhagen.